Revenue and EPS has stalled, not clear consistency.
Short Interest: 1.98%
ADR 5.17%
Does it respect the H1 100SMA (Min 3Months): Yes
Both founders have around 45M units of stock left after selling in Sep (8M units), Apr (1.6M units)
4 Nov, Hindenburg has done a short report leading to a gap down and decline of almost 60%. hindenburgresearch.com/pacs/
26 Nov PACS Group receives NYSE non-compliance notice
Is it a Hype Thematic (AI, Solar): Potential US healthcare
100SMA StrongWeak Bounce 🏀 (0.5R) v1.0
Trading risk at 0.5R as we are testing this strategy
This trade model is based on us riding the 100SMA trend waves of the strongest and weakest companies. It only executes well when greater force (RUT & SPX) is trending. Entries are at greater force key levels when it is consolidating. When greater force is taking off it is too late.
Entry
Within Stdev 100 zone
SL = ATR14 * 2 (Run full course no early exits)
Trailing stop (Previous Day Low or high)
Price launch off (D1)
D2 Closes
D3 Move SL to D2 Low
Note
Scaling up 1.1R since price has made a new low
Note
Scaled again because while the other stocks we tracked were becoming bullish, PACS was the opposite and continued bearish. With our adjusted SL this was a USD100 bet vs a potential >2R return, it was good EV to let run into the Fed announcement and the bet paid off.
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.